The study identifies nuclear retention of mutant transcripts as a novel mechanism for loss of gene function in myotonic dystrophy.
Answers are grounded in this paper and cite their sources.
May explain DMPK loss via nuclear retention in myotonic dystrophy models; leaves open human relevance and therapeutic targeting.
Expansion of a CTG trinucleotide repeat in the 3' untranslated region (UTR) of DMPK, the gene encoding myotonic dystrophy protein kinase, induces the dominantly inherited neuromuscular disorder myotonic dystrophy (DM). Transcripts containing the expanded trinucleotide are abundant in differentiated cultured myoblasts, and they are spliced and polyadenylylated normally. However, mutant transcripts never reach the cytoplasm in these nonmitotic cells; instead, they form stable clusters that are tightly linked to the nuclear matrix, which can prevent effective biochemical purification of these transcripts. In DM patients, reduced DMPK protein levels, consequent to nuclear retention of mutant transcripts, are probably a cause of disease development. Formation of nuclear foci is a novel mechanism for preventing transcript export and effecting a loss of gene function.
No takes yet. Share an insight, caveat, or question.
Davis et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: